Mirick GR[au] - Search Results

Year	Number of Results
1978	1
1986	2
1987	1
1993	1
1994	1
1995	2
1996	1
1998	4
1999	6
2001	2
2003	5
2004	1
2007	2
2008	1
2009	1
2024	0

1

Human antiglobulin response to foreign antibodies: therapeutic benefit?

DeNardo GL, Bradt BM, Mirick GR, DeNardo S. DeNardo GL, et al. Among authors: mirick gr. Cancer Immunol Immunother. 2003 May;52(5):309-16. doi: 10.1007/s00262-002-0350-y. Epub 2003 Mar 4. Cancer Immunol Immunother. 2003. PMID: 12700946 Review.

2

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.

Mirick GR, Bradt BM, Denardo SJ, Denardo GL. Mirick GR, et al. Q J Nucl Med Mol Imaging. 2004 Dec;48(4):251-7. Q J Nucl Med Mol Imaging. 2004. PMID: 15640788 Free article. Review.

3

Milestones in the development of Lym-1 therapy.

DeNardo GL, O'Donnell RT, Rose LM, Mirick GR, Kroger LA, DeNardo SJ. DeNardo GL, et al. Among authors: mirick gr. Hybridoma. 1999 Feb;18(1):1-11. doi: 10.1089/hyb.1999.18.1. Hybridoma. 1999. PMID: 10211782 Review.

4

Antibody responses to macrocycles in lymphoma.

DeNardo GL, Mirick GR, Kroger LA, O'Donnell RT, Meares CF, DeNardo SJ. DeNardo GL, et al. Among authors: mirick gr. J Nucl Med. 1996 Mar;37(3):451-6. J Nucl Med. 1996. PMID: 8772643 Free article.

5

L6 monoclonal antibody binds prostate cancer.

O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. O'Donnell RT, et al. Among authors: mirick gr. Prostate. 1998 Oct 1;37(2):91-7. doi: 10.1002/(sici)1097-0045(19981001)37:2<91::aid-pros5>3.0.co;2-o. Prostate. 1998. PMID: 9759703

6

A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.

O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Carr CE, Mirick GR, DeNardo SJ. O'Donnell RT, et al. Among authors: mirick gr. J Nucl Med. 1999 Dec;40(12):2014-20. J Nucl Med. 1999. PMID: 10616879 Free article. Clinical Trial.

7

Metabolite production in patients with lymphoma after radiometal-labeled antibody administration.

DeNardo GL, DeNardo SJ, Kukis DL, O'Donnell RT, Shen S, Mirick GR, Meares CF. DeNardo GL, et al. Among authors: mirick gr. J Nucl Med. 2001 Sep;42(9):1324-33. J Nucl Med. 2001. PMID: 11535720 Free article.

8

Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.

Kukis DL, DeNardo GL, DeNardo SJ, Mirick GR, Miers LA, Greiner DP, Meares CF. Kukis DL, et al. Among authors: mirick gr. Cancer Res. 1995 Feb 15;55(4):878-84. Cancer Res. 1995. PMID: 7850803

9

Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1.

De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. De Nardo GL, et al. Among authors: mirick gr. Int J Biol Markers. 1995 Apr-Jun;10(2):67-74. doi: 10.1177/172460089501000201. Int J Biol Markers. 1995. PMID: 7561241 Clinical Trial.

10

Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts.

O'Donnell RT, DeNardo SJ, Miers LA, Kukis DL, Mirick GR, Kroger LA, DeNardo GL. O'Donnell RT, et al. Among authors: mirick gr. Cancer Biother Radiopharm. 1998 Oct;13(5):351-61. doi: 10.1089/cbr.1998.13.351. Cancer Biother Radiopharm. 1998. PMID: 10851425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year